200 related articles for article (PubMed ID: 12562873)
1. Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis.
Schonfeld G; Patterson BW; Yablonskiy DA; Tanoli TS; Averna M; Elias N; Yue P; Ackerman J
J Lipid Res; 2003 Mar; 44(3):470-8. PubMed ID: 12562873
[TBL] [Abstract][Full Text] [Related]
2. Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity.
Tanoli T; Yue P; Yablonskiy D; Schonfeld G
J Lipid Res; 2004 May; 45(5):941-7. PubMed ID: 14967820
[TBL] [Abstract][Full Text] [Related]
3. Decreased production rates of VLDL triglycerides and ApoB-100 in subjects heterozygous for familial hypobetalipoproteinemia.
Elias N; Patterson BW; Schonfeld G
Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2714-21. PubMed ID: 10559016
[TBL] [Abstract][Full Text] [Related]
4. Absence of fatty liver in familial hypobetalipoproteinemia linked to chromosome 3p21.
Yue P; Tanoli T; Wilhelm O; Patterson B; Yablonskiy D; Schonfeld G
Metabolism; 2005 May; 54(5):682-8. PubMed ID: 15877300
[TBL] [Abstract][Full Text] [Related]
5. Reduced intestinal fat absorptive capacity but enhanced susceptibility to diet-induced fatty liver in mice heterozygous for ApoB38.9 truncation.
Lin X; Yue P; Xie Y; Davidson NO; Sakata N; Ostlund RE; Chen Z; Schonfeld G
Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G146-52. PubMed ID: 15790761
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein B gene mutations and fatty liver in Japanese hypobetalipoproteinemia.
Katsuda S; Kawashiri MA; Inazu A; Tada H; Tsuchida M; Kaneko Y; Nozue T; Nohara A; Okada T; Kobayashi J; Michishita I; Mabuchi H; Yamagishi M
Clin Chim Acta; 2009 Jan; 399(1-2):64-8. PubMed ID: 18848826
[TBL] [Abstract][Full Text] [Related]
7. Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia.
Di Filippo M; Moulin P; Roy P; Samson-Bouma ME; Collardeau-Frachon S; Chebel-Dumont S; Peretti N; Dumortier J; Zoulim F; Fontanges T; Parini R; Rigoldi M; Furlan F; Mancini G; Bonnefont-Rousselot D; Bruckert E; Schmitz J; Scoazec JY; Charrière S; Villar-Fimbel S; Gottrand F; Dubern B; Doummar D; Joly F; Liard-Meillon ME; Lachaux A; Sassolas A
J Hepatol; 2014 Oct; 61(4):891-902. PubMed ID: 24842304
[TBL] [Abstract][Full Text] [Related]
8. Familial hypobetalipoproteinemia: genetics and metabolism.
Schonfeld G; Lin X; Yue P
Cell Mol Life Sci; 2005 Jun; 62(12):1372-8. PubMed ID: 15818469
[TBL] [Abstract][Full Text] [Related]
9. Greater dietary fat oxidation in obese compared with lean men: an adaptive mechanism to prevent liver fat accumulation?
Hodson L; McQuaid SE; Humphreys SM; Milne R; Fielding BA; Frayn KN; Karpe F
Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E584-92. PubMed ID: 20628024
[TBL] [Abstract][Full Text] [Related]
10. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.
Riches FM; Watts GF; Naoumova RP; Kelly JM; Croft KD; Thompson GR
Int J Obes Relat Metab Disord; 1998 May; 22(5):414-23. PubMed ID: 9622338
[TBL] [Abstract][Full Text] [Related]
11. Fatty liver and insulin resistance: not always linked.
Schonfeld G; Yue P; Lin X; Chen Z
Trans Am Clin Climatol Assoc; 2008; 119():217-23; discussion 223-4. PubMed ID: 18596860
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein Metabolism in APOB L343V Familial Hypobetalipoproteinemia.
Hooper AJ; Heeks L; Robertson K; Champain D; Hua J; Song S; Parhofer KG; Barrett PH; van Bockxmeer FM; Burnett JR
J Clin Endocrinol Metab; 2015 Nov; 100(11):E1484-90. PubMed ID: 26323024
[TBL] [Abstract][Full Text] [Related]
13. Familial hypobetalipoproteinemia: a review.
Schonfeld G
J Lipid Res; 2003 May; 44(5):878-83. PubMed ID: 12639976
[TBL] [Abstract][Full Text] [Related]
14. Familial hypobetalipoproteinemia in a hospital survey: genetics, metabolism and non-alcoholic fatty liver disease.
Gutiérrez-Cirlos C; Ordóñez-Sánchez ML; Tusié-Luna MT; Patterson BW; Schonfeld G; Aguilar-Salinas CA
Ann Hepatol; 2011; 10(2):155-64. PubMed ID: 21502677
[TBL] [Abstract][Full Text] [Related]
15. A targeted apoB38.9 mutation in mice is associated with reduced hepatic cholesterol synthesis and enhanced lipid peroxidation.
Lin X; Chen Z; Yue P; Averna MR; Ostlund RE; Watson MA; Schonfeld G
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1170-6. PubMed ID: 16455790
[TBL] [Abstract][Full Text] [Related]
16. Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease.
Fabbrini E; Mohammed BS; Korenblat KM; Magkos F; McCrea J; Patterson BW; Klein S
J Clin Endocrinol Metab; 2010 Jun; 95(6):2727-35. PubMed ID: 20371660
[TBL] [Abstract][Full Text] [Related]
17. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.
Fabbrini E; Mohammed BS; Magkos F; Korenblat KM; Patterson BW; Klein S
Gastroenterology; 2008 Feb; 134(2):424-31. PubMed ID: 18242210
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein metabolism in an apoB-80 familial hypobetalipoproteinemia heterozygote.
Hooper AJ; Robertson K; Champain D; Hua J; Song S; Parhofer KG; Barrett PHR; van Bockxmeer FM; Burnett JR
Clin Biochem; 2016 Jun; 49(9):720-722. PubMed ID: 26916057
[TBL] [Abstract][Full Text] [Related]
19. Postprandial lipoprotein metabolism in familial hypobetalipoproteinemia.
Hooper AJ; Robertson K; Barrett PH; Parhofer KG; van Bockxmeer FM; Burnett JR
J Clin Endocrinol Metab; 2007 Apr; 92(4):1474-8. PubMed ID: 17213276
[TBL] [Abstract][Full Text] [Related]
20. Association between skeletal muscle fat content and very-low-density lipoprotein-apolipoprotein B-100 transport in obesity: effect of weight loss.
Chan DC; Gan SK; Wong AT; Barrett PH; Watts GF
Diabetes Obes Metab; 2014 Oct; 16(10):994-1000. PubMed ID: 24821431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
